Page 5 - CJO_DIABETES_ENG_W17
P. 5
CLINICAL RESEARCH C
2017 CAO Clinical Practice Guideline:
Optometric Care of the Patient with Diabetes
Chris Hudson, Introduction
BSc (Hons), PhD,
MCOptom (UK), PgCUT; The Canadian Association of Optometrists (CAO) is the national voice of
University of Waterloo optometry and is dedicated to collaboratively advancing the highest stan-
dard of primary eye care through the promotion of optimal vision and eye
Dianna Leong, BSc, OD; health, in partnership with all Canadians.
Foresight Eyecare
Optometrists are the front line of eye health and vision care. They are ex-
Erin Loewen, BSc, OD; perts in primary eye care and are well-positioned to help combat the vision-
Village Optical related complications of diabetes.
Derek MacDonald CAO assembled the Diabetes Guidelines Working Group to create national
OD, FAAO; guidelines on the clinical management of diabetes mellitus in an effort to
Ilex Eye Associates further educate Canadian optometrists and assist them in the management
of this chronic disease. The Working Group consists of optometrists from
private practice, research and academia, chosen on the basis of their exper-
Angie Machmer, OD; tise, experience and representation from across Canada.
Emerald Park Eye Care,
THE DIABETES GUIDELINES WORKING GROUP MEMBERS ARE:
Ken Mandadakis, BSc, OD; Chris Hudson, BSc (Hons), PhD, MCOptom (UK), PgCUT;
Dr. Ken Mandadakis University of Waterloo, Waterloo, ON
& Associates Dianna Leong, BSc, OD; Foresight Eyecare, Calgary, AB
Erin Loewen, BSc, OD; Village Optical, Winnipeg, MB
Henry Smit, OD; Derek MacDonald OD, FAAO; Ilex Eye Associates, Waterloo, ON
FYidoctors Angie Machmer, OD; Emerald Park Eye Care, Emerald Park, SK
Ken Mandadakis, BSc, OD; Dr. Ken Mandadakis & Associates, Toronto, ON
Nohad Teliani, BSs, OD; Henry Smit, OD; FYidoctors, Truro, NS
Eye Care Solutions Nohad Teliani, BSs, OD; Eye Care Solutions, Edmonton, AB
Benoit Tousignant, OD, MSc, MPH, FAAO; University of Montreal,
Benoit Tousignant, Montreal, QC
OD, MSc, MPH, FAAO;
University of Montreal EDITING WAS COMPLETED BY:
Chris Hudson, BSc (Hons), PhD, MCOptom (UK), PgCUT;
University of Waterloo, Waterloo, ON
Derek MacDonald, OD, FAAO; Ilex Eye Associates, Waterloo, ON
Tracy Murphy, MHA, CHE, Consultant, Ottawa, ON
Lois Ross, Editor, Ottawa, ON
DISCLOSURE STATEMENT
The publication of this Guideline was made possible with an unrestricted edu-
cational grant from Optos Inc.
DISCLAIMER
These guidelines do not represent a standard of care. Instead, they are
intended to assist the clinician in the decision-making process. Patient
care and treatment should always be based on a clinician’s independent
professional judgment, given the patient’s circumstances, and in compli-
ance with applicable laws and regulations.
The information in this guideline is current to the extent possible at the
time of publication.
CANADIAN JOURNAL of OPTOMETRY | REVUE CANADIENNE D’OPTOMÉTRIE VOL. 79 SUPPLEMENT 2, 2017 5
